We examined the effects of disulfide and thiol compounds on Escherichia coli heat-stable enterotoxin (ST) and cyclic GMP-induced secretion. Both cystamine and cystine (disulfide compounds) reduced the secretory responses to submaximal doses of ST in suckling mice (at 0.5 ,umol per mouse) and reduced ST activation of guanylate cyclase (by 33 to 73% at 1 mM). In higher doses, cystamine completely eradicated a maximally effective ST dose as well. In addition, the sulfhydryl (thiol) compounds cysteamine, cysteine, and acetylcysteine strikingly reduced the secretory response and the guanylate cyclase response to ST. Neither the disulfide nor the thiol compounds tested reduced cyclic GMP-induced secretion. These studies suggest that disulfide and thiol compounds both block ST-induced secretion before its activation of guanylate cyclase. Taken with the work of others, these findings suggest that disulfide compounds may alter the oxidation reduction state of a cell or act directly on the guanylate cyclase enzyme, whereas thiol compounds may inactivate ST itself by breaking its disulfide bridges, or it may alter guanylate cyclase activation by ST. Both families of compounds deserve further consideration among potential antisecretory agents for application in the control of ST-induced diarrhea.
The morbidity and mortality associated with Escherichia coli enterotoxigenic diarrheal illness should be reduced by pharmacological inhibition of the action of E. coli enterotoxins (both heatstable [ST] and heat-labile enterotoxins). Methanol-soluble ST, active in suckling mice, specifically activates the particulate fraction of guanylate cyclase in intestinal mucosal cells (14, 23 ; J. M. Hughes, F. Murad, and R. L. Guerrant, Clin. Res. 26:524A, 1978) , resulting in increased mucosal cell cyclic GMP (cGMP) levels and a net increase in intestinal fluid secretion (26) . A second E. coli ST (STb) has recently been described. STb is methanol insoluble, inactive in suckling mice, and has a mechanism of action which does not increase intestinal mucosal cell cGMP (7, 24 ; R. N. Greenberg 30:367A, 1982 ). E. coli heat-labile enterotoxin has a mechanism of action similar to that of choleratoxin (8, 12, 21, 22) . In this study, we examined a possible pharmacological blockade of intestinal secretion induced by the suckling mouse-active ST.
Although the precise regulation of guanylate cyclase activity and cGMP accumulation in vivo are unknown, several studies suggest that free radicals activate guanylate cyclase and that guanylate cyclase activity is influenced by the oxidation reduction state of the cell and by intracellular levels of thiols and disulfides (5, 6, 9, 29, 32, 33, 40) . Butylated hydroxyanisole, a free radical scavenger, significantly but incompletely reduces ST activation of guanylate cyclase and ST-induced intestinal fluid secretion (23) . Hydroxylamine, an agent that activates guanylate cyclase by the production of free radicals (30) , also causes intestinal ion transport alterations similar to those seen with ST (13 (37) .
In this study, we evaluated the effect of cystamine and related sulfhydryl and disulfide compounds on (i) ST-induced intestinal fluid secretion, (ii) ST activation of guanylate cyclase, and (iii) 8 Guanylate cyclase assay. Guanylate cyclase activity was determined as previously described (18) . The cGMP formed was measured by radioimmunoassay with acetylation of samples (New England Nuclear Corp., Boston, Mass.) (5, 25) . Protein was solubilized in 1 N NaOH and quantitated by the method of Lowry et al. (31) with bovine serum albumin as the standard.
Suckling mouse assay. The suckling mouse assay was performed as previously described (19 activity to 61 ± 5 pmol of cGMP per mg of protein per 10 min. Two other disulfide compounds, L-cystine and D-cystine, were also tested. Because of the precipitation of these reagents, concentrations greater than 1 mM could not be studied. At 1 mM, neither drug affected basal activity, but both L-cystine and D-cystine inhibited ST-induced activity of guanylate cyclase. Among the thiol compounds, cysteamine (1 mM) inhibited ST-induced guanylate cyclase activity but not basal enzyme activity. At a higher concentration (10 mM), cysteamine did not significantly reduce basal activity but further reduced ST-induced activity (from 201 ± 13 to 75 ± 2 pmol of cGMP per mg of protein per 10 min). None of the other sulfhydryl compounds (1 mM) affected basal enzyme activity, but each (except D-cysteine) significantly reduced ST-induced enzyme activity. At 10 mM, these compounds did not significantly alter basal activity but did inhibit ST-activated enzyme activity by 38 to 57%. At 10 mM, D-cysteine also acted like the other thiol compounds: it did not significantly alter basal activity but did inhibit ST-activated enzyme activity by 46% (P < 0.001).
Cystathionine, a compound consisting of serine and homocysteine linked by a sulfur molecule ( Fig. 1) , had no effect on either basal or STinduced enzyme activity. Cystathionine was examined because of its structural resemblance to the disulfides and sulfhydryl agents, with the important difference of not having its sulfur as a disulfide or thiol.
Inhibition of ST-induced fluid secretion in suckling mice. We found significant inhibition of STinduced fluid secretion by all sulfhydryl and disulfide compounds but not by cystathionine (Table 2) . Each agent was examined both by s.c. and i.g. administration.
Cystamine. Among the disulfides studied, cystamine demonstrated the most inhibition of STmediated intestinal fluid secretion. At 0.5 ,umol per mouse, cystamine given s.c. significantly reduced ST-induced intestinal fluid secretion by either 1.6 or 6.4 ST units (Fig. 2) . Cystamine at 0.5 ,umol per mouse i.g. did not significantly affect ST-induced secretion. However, at the 1-log-higher dose (5 ,umol per mouse) either s.c. or i.g., cystamine significantly reduced ST-induced secretion (Fig. 2) . In prior experiments, we have found that certain agents such as chlorpromazine alter unstimulated (no ST added) gut to remaining body weight ratios (19 Because of solubility problems, higher concentrations of the drug were not studied, and we cannot be sure that at a higher concentration inhibitory effects would not be evident. Lack of inhibition of 8-bromo cGMP-induced intestinal secretion. We examined the effects of the disulfide agents, thiol compounds, and cystathionine on 8-bromo cGMP-induced intestinal fluid secretion in suckling mice (26) . As reported in Table 3 , no agent given either s.c. or i.g. (37) . Most other purified preparations of ST contain multiple residues of half-cystine (1, 15, 28) .
It is also possible that thiol or disulfide reagents affect the binding of ST to its receptor or inhibit steps beyond toxin binding that result from mucosal cell exposure to ST. The enterotoxin effects of ST have been recently reviewed, and many investigators have noted that ST causes an increase in intestinal cell cGMP concentrations (17) . It has been shown that disulfide compounds such as cystamine and thiol compounds have very marked effects on guanylate cyclase activity (6, 32) . Investigators have speculated that these agents alter the oxidation reduction state of cellular components (possibly by free radical scavenging) and thus alter guanylate cyclase activity. In addition, Brandwein et al. have shown that when [35S]cystine and purified soluble guanylate cyclase are incubated together, the radioactivity is incorporated into the enzyme, and there is a reversible loss of enzyme activity (5) .
In this study, we examined the effects of various disulfide and thiol compounds on STinduced intestinal secretions in suckling mice, ST activation of guanylate cyclase, and cGMPinduced intestinal secretions in suckling mice. Our results show that the disulfide compound cystamine alters guanylate cyclase activity. The fact that cystamine inhibits ST-activated guanylate cyclase significantly more than basal activity suggests that cystamine limits maximal guanylate cyclase activity or that it may have an additional effect on ST or on ST binding. Cystamine has no effect on 8-bromo cGMP-induced intestinal secretion. Similar but less effective results were seen with D-and L-cystine. The inhibition of ST-induced secretion by the disulfides cystamine and cystine clearly occurs before the formation of cGMP.
The sulfhydryl compounds (cysteamine, acetylcysteine, and D-and L-cysteine, each at 1 mM) do not alter basal guanylate cyclase activity; each, however, reduces ST-stimulated guanylate cyclase activity and ST-induced fluid secretion in the suckling mouse. None of the thiol agents could alter 8-bromo cGMP-induced intestinal secretion. Thiols seem to be more specific inhibitors of ST than disulfides, as none showed significant alteration of basal guanylate cyclase activity. Like the disulfide agents, thiol compounds inhibit ST effects before the formation of cGMP. Thiol compounds probably reduce the disulfide bonds of ST which are necessary for its biological activity. The clearance and metabolism of these agents, although not well understood, probably relate to local redox conditions and pH and may explain why thiol derivatives inhibit best when given i.g. and disulfide agents inhibit best when given s.c. The sulfur-containing compound cystathionine shows no alteration of basal or ST-or cGMP-induced responses. These results further suggest that it is the sulfhydryl group or the presence of a disulfide bond that seems necessary for compounds to inhibit ST activity. Until now, research with thiols and disulfides as therapeutic agents has centered on their radioprotective properties (3, 4, 34, 39) and their efficacy in the treatment of acetaminophen overdoses (2, 11, 27, 35, 36) and nephropathic cystinosis (38, 41) .
In summary, selected disulfide and thiol compounds inhibit ST-mediated fluid secretion before ST-induced formation of cGMP. Cysteamine seemed the most effective inhibitory agent. Cysteamine may directly alter the toxin. In contrast, the disulfide compound cystamine clearly appeared to have a nonspecific inhibitory effect, perhaps by altering the cyclase enzyme directly. Future research, evaluating disulfide and thiol compounds as inhibitors of intestinal secretion induced by ST and possibly by other enterotoxins, may lead to an effective antisecretory agent for enterotoxin-induced diarrhea.
